经尿道膀胱肿瘤等离子整块剜除术与经尿道膀胱肿瘤电切术在非肌层浸润性膀胱癌中的应用效果

Abstract
Figure/Table
References (22)
Related Citation (15)

Download: PDF (0 KB) HTML (38 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To compare and analyze the clinical efficacy and 1-year follow-up of transurethral plasma enucleation of bladder tumor(TeURBT)and transurethral resection of bladder tumor(TURBT)in the treatment of non-muscular invasive bladder cancer.Methods A retrospective analysis of 92 patients with non-muscular invasive bladder cancer admitted to the Department of Urology in the Dandong Central Hospital from June 2018 to December 2019 was conducted.They were divided into the group A and the group B according to different surgical methods,with 46 patients in each group.The group A were given TURBT operation and the group B were given TeURBT operation.The perioperative indicators,complications,serum indicators and recurrence were compared and analyzed between the two groups.Results The operation time in the group B was longer than that in the group A,while the duration of catheter indwelling,bladder irrigation and hospitalization in the group B were shorter than those in the group A,and the blood loss during operation in the group B was less than that in the group A,with statistically significant differences(P<0.05).The total incidences of postoperative complications in the group B was lower than that in the group A,with statistically significant difference(P<0.05).The expressions of monocyte chemoattractant protein-1(MCP-1),human cartilage glycoprotein-39 (YKL40)and vascular endothelial growth factor(VEGF)at the time of reexamination were lower than those before surgery,with statistically significant differences(P<0.05).But there were no statistically significant differences of MCP-1,YKL40 and VEGF between the two groups (P>0.05).The cumulative recurrence rate at 1 year after operation in the group B was 6.52%,which was lower than that in the group A as 21.74%,with statistically significant difference (P<0.05).Conclusion Both TeURBT and TURBT can achieve significant effects in the treatment of nonmuscular invasive bladder cancer,but TeURBT has more advantages in improving perioperative indicators,and reducing incidence of complications and recurrence rate.

Key words： Transurethral plasma enucleation of bladder tumor Transurethral resection of bladder tumor Non-muscular invasive bladder cancer Clinical efficacy Recurrence

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHANG Shou-peng

Cite this article:

ZHANG Shou-peng. Application of transurethral plasma enucleation of bladder tumor and transurethral resection of bladder tumor in non-muscular invasive bladder cancer[J]. 中国当代医药, 2021, 28(32): 95-98.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I32/95

[1]	Gun，Danielsson，Per-uno，et al.Bladder health in patients treated with BCG instillations for T1G2-G3 bladder cancer-a follow-up five years after the start of treatment[J].Scand J Urol，2019，52（5-6）：377-384.
[2]	郭长刚，包国昌，高志明，等.2μm激光整块切除与电切治疗非肌层浸润性膀胱癌的临床分析[J].现代肿瘤医学，2020，28（13）：106-109.
[3]	江冰华，曹全富，冯庆兴.老年非肌层浸润性膀胱癌经尿道电切术后吉西他滨膀胱灌注的疗效[J].实用医学杂志，2019，35（13）：2125-2127.
[4]	白冰，母健君，王岭，等.两种经尿道膀胱肿瘤切除术治疗非肌层浸润性膀胱癌的效果对比及对患者生活质量的影响[J].微创泌尿外科杂志，2020，9（1）：39-43.
[5]	刘安全，李杰，代苗英，等.TURBT+吉西他滨膀胱热灌注对高危非肌层浸润性膀胱癌的应用价值[J].广东医学，2020，41（9）：925-928.
[6]	王伟，周红庆，刘明生，等.经尿道膀胱肿瘤等离子整块剜除术与传统电切术的对比研究[J].微创泌尿外科杂志，2020，9（4）：115-119.
[7]	那彦群.中国泌尿外科疾病诊断治疗指南[S].北京：人民卫生出版社，2013：54-56.
[8]	Pecoraro M，Takeuchi M，Vargas HA，et al.Overview of VIRADS in Bladder Cancer[J].Am J Roentgenol，2020，214（6）：1-10.
[9]	张建斌.经尿道膀胱肿瘤剜除术治疗非肌层浸润性膀胱癌临床效果[J].中国药物与临床，2020，20（22）：109-111.
[10]	张申平，杨进益.经尿道钬激光切除术对非肌层浸润性膀胱癌患者术后恢复及复发率的影响[J].山西医药杂志，2020，49（5）：65-67.
[11]	谢汉平，王涛，潘铁军.经尿道激光剜除与电切治疗非肌层浸润性膀胱肿瘤围手术期的比较研究[J].华南国防医学杂志，2019，33（2）：92-95.
[12]	杨勇军，杨晓峰，刘晨.常规电切环逆推法经尿道膀胱肿瘤整块剜除术的疗效及技巧探讨[J].中华泌尿外科杂志，2019，40（2）：144-146.
[13]	冯权尧，徐勋，赵振华，等.经尿道钬激光切除术与等离子电切术治疗非肌层浸润性膀胱癌的疗效分析[J].现代泌尿生殖肿瘤杂志，2019，11（1）：29-32，47.
[14]	熊军，舒方国.经尿道内镜黏膜下剥离术与经尿道膀胱肿瘤电切术治疗非肌层浸润性膀胱癌的效果比较[J].中国肿瘤临床与康复，2020，27（5）：93-96.
[15]	李昱亮，庞建，魏琪波.经尿道膀胱肿瘤整块切除术治疗非肌层浸润性膀胱癌的疗效分析[J].癌症进展，2019，17（11）：1296-1298.
[16]	刘继普，钟煜韡，郑永宏.膀胱部分切除术对局限性肌层浸润性膀胱癌患者血清VEGF，MCP-1的影响[J].西部医学，2020，32（2）：84-87.
[17]	Suzuki H，Boki H，Kamijo H，et al.YKL-40 Promotes Proliferation of Cutaneous T-Cell Lymphoma Tumor Cells through Extracellular Signal-Regulated Kinase Pathways[J].J Invest Dermatol，2020，140（4）：860-868.
[18]	李伟，刘昊.铜绿假单胞菌注射液膀胱灌注预防非肌层浸润性膀胱癌术后复发的有效性及对患者生活质量和血清 VEGF 的影响[J].临床泌尿外科杂志，2020，35（2）：133-136.
[19]	张伟，卢勇，郭高伟.根治性经尿道膀胱肿瘤电切术治疗老年肌层浸润性膀胱癌的临床效果[J].中国当代医药，2020，27（11）：84-87.
[20]	王永顺，王永刚，祁岳鸿.不同术式治疗非肌层浸润性膀胱癌的临床研究[J].中国现代医生，2019，57（12）：46-49.
[21]	罗超，甘泉，柯莽，等.经尿道二次电切联合膀胱灌注预防高危非肌层浸润性膀胱癌术后复发的效果[J].中国现代医生，2020，58（9）：25-28.
[22]	彭晓文，麦周明，罗柏威，等.经尿道铥激光与等离子电切治疗非肌层浸润性膀胱肿瘤疗效比较的荟萃分析[J].当代医学，2020，26（16）：95-99.